Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01558778 | Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Jul 9, 2012 | clinicaltrials |
| NCT01035437 | Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 |
| Jul 2, 2012 |
| clinicaltrials |
| NCT00054470 | Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 0 | Jun 29, 2012 | clinicaltrials |
| NCT01314677 | Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 0 | Jun 29, 2012 | clinicaltrials |
| NCT01333423 | Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC) | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jun 26, 2012 | clinicaltrials |
| NCT00321347 | Intravenous (IV) Lidocaine for Opioid-refractory Pain | withdrawn | Phase 2 | 0 | San Diego Hospice & Palliative CareOTHER | 1 | Jun 22, 2012 | clinicaltrials |
| NCT01203579 | Chest Computed Tomography (CT) Screening Study With Antibody Testing | withdrawn | — | 0 | Mayo ClinicOTHER | 1 | Jun 21, 2012 | clinicaltrials |
| NCT01290406 | BEZ235 Trial in Patients With Advanced Endometrial Carcinoma | withdrawn | Phase 2 | 0 | Novartis PharmaceuticalsINDUSTRY | 12 | Jun 21, 2012 | clinicaltrials |
| NCT00886496 | Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia | withdrawn | Phase 1 | 0 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00084435 | S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer(S0217) | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00057928 | S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer | withdrawn | Phase 3 | 0 | SWOG Cancer Research NetworkNETWORK | 2 | Jun 13, 2012 | clinicaltrials |
| NCT00057993 | Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer | withdrawn | Phase 2 | 0 | Northwestern UniversityOTHER | 0 | Jun 11, 2012 | clinicaltrials |
| NCT01313104 | Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer | withdrawn | N/A | 0 | Northwestern UniversityOTHER | 0 | Jun 11, 2012 | clinicaltrials |
| NCT01327521 | Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma | withdrawn | Phase 3 | 0 | Albert KoongOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00070434 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Jun 7, 2012 | clinicaltrials |
| NCT01288092 | BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer | withdrawn | Phase 2 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Jun 7, 2012 | clinicaltrials |
| NCT00242931 | Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy | withdrawn | Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Jun 1, 2012 | clinicaltrials |
| NCT00403182 | Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer | withdrawn | Phase 3 | 0 | Technical University of MunichOTHER | 1 | Jun 1, 2012 | clinicaltrials |
| NCT00935558 | Dendritic Cell Based Therapy for Breast Cancer Patients | withdrawn | Phase 2 | 0 | Inge Marie SvaneOTHER | 1 | May 31, 2012 | clinicaltrials |
| NCT01491139 | Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck(ORCA) | withdrawn | Phase 1 | 0 | University College, LondonOTHER | 0 | May 30, 2012 | clinicaltrials |
| NCT00244920 | Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer | withdrawn | Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | May 28, 2012 | clinicaltrials |
| NCT01031056 | Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers | withdrawn | — | 0 | Stanford UniversityOTHER | 1 | May 28, 2012 | clinicaltrials |
| NCT00415376 | Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases | withdrawn | N/A | 0 | Northwestern UniversityOTHER | 0 | May 18, 2012 | clinicaltrials |
| NCT00734773 | Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL | withdrawn | Early Phase 1 | 0 | Northwestern UniversityOTHER | 0 | May 18, 2012 | clinicaltrials |
| NCT01151748 | Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma | withdrawn | Phase 2 | 0 | Stanford UniversityOTHER | 1 | May 14, 2012 | clinicaltrials |
| NCT01492881 | Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma | withdrawn | Phase 2 | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00090701 | A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer | withdrawn | Phase 2 | 0 | PfizerINDUSTRY | 1 | May 10, 2012 | clinicaltrials |
| NCT00570999 | Palifermin After Haploidentical PBSCT(KGF Haplo Allo) | withdrawn | Phase 2 | 0 | European Society for Blood and Marrow TransplantationNETWORK | 1 | May 10, 2012 | clinicaltrials |
| NCT01203163 | Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes(CALIPSO) | withdrawn | — | 0 | Pinnacle Biologics Inc.INDUSTRY | 0 | May 9, 2012 | clinicaltrials |
| NCT00343447 | Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia | withdrawn | Phase 2 | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 3, 2012 | clinicaltrials |
| NCT00312637 | Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease | withdrawn | N/A | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 1, 2012 | clinicaltrials |
| NCT00083044 | Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy | withdrawn | — | 0 | Northwestern UniversityOTHER | 1 | Apr 25, 2012 | clinicaltrials |
| NCT00442741 | Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) | withdrawn | Phase 1 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Apr 25, 2012 | clinicaltrials |
| NCT00005827 | Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer | withdrawn | Phase 1 | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00985036 | Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients | withdrawn | — | 0 | Marquette General Health SystemOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00813254 | Cost Utility Analysis in Recurrent Ovarian Cancer | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT01024114 | Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality | withdrawn | — | 0 | Mayo ClinicOTHER | 1 | Apr 18, 2012 | clinicaltrials |
| NCT01194206 | Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Apr 18, 2012 | clinicaltrials |
| NCT01196000 | Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By Surgery | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 0 | Apr 17, 2012 | clinicaltrials |
| NCT00515957 | Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)(DELLA) | withdrawn | Phase 1 | 0 | Baylor College of MedicineOTHER | 0 | Apr 16, 2012 | clinicaltrials |
| NCT00962572 | The Effects of Aggressive Patient Management on Cancer Therapy Management | withdrawn | — | 0 | University of Mississippi Medical CenterOTHER | 1 | Apr 9, 2012 | clinicaltrials |
| NCT01045044 | Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy | withdrawn | — | 0 | Kettering Health NetworkOTHER | 1 | Apr 5, 2012 | clinicaltrials |
| NCT01409226 | 3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk Women | withdrawn | N/A | 0 | NYU Langone HealthOTHER | 1 | Apr 5, 2012 | clinicaltrials |
| NCT01445587 | A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma | withdrawn | Phase 2 | 0 | GlaxoSmithKlineINDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019409 | Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia | withdrawn | Phase 3 | 0 | National Institutes of Health Clinical Center (CC)NIH | 2 | Mar 23, 2012 | clinicaltrials |
| NCT00503932 | Proton Therapy With Capecitabine for Rectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT01353482 | A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma(MESO-02) | withdrawn | Phase 1 / Phase 2 | 0 | University College, LondonOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT00003929 | Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00402935 | Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jul 9, 2012source: clinicaltrials